L7 Defense, a Jersey City, N.J.-based cyber security technology company, completed a financing round of $4m.
The round was led by TRUMPF Venture with participation from Quick Heal Technologies.
The company intends to use the funds to solidify its technological leadership, boost its marketing and business development activities, and extend its market reach.
Led by Dr. Doron Chema, Co-founder and CEO, and Yisrael Gross, co-founder and VP Business Development, L7 Defense provides the Ammune™ enterprise-grade API (application programming interface) security solution that protects APIs and API-based applications from related threats, while utilizing unsupervised, innovative AI/ML technology.
It is deployed at financial, telecom and SaaS sectors in North America, Europe, and APAC.